We propose that this mechanism is activated by a ligand-receptor interaction between TGF-β1, found in CML-derived exosomes, and the TGF- β1 receptor in CML cells. Here, TGFB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.